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presence of fat introduces additional signal 
modulations with TE that are manifest as a 
positive bias in the apparent R2* [8], making 
the accuracy of R2* assessment dependent on 
the specific TEs used. The difference in res-
onance frequency between fat and water al-
lows the TE-dependent signal modulation to 
be minimized by acquiring images at TEs 
that are multiples of 2.3 ms (at 1.5 T) where 
off-resonance precession places water and fat 
magnetization approximately in phase and in 
antiphase. However, in heavily iron-overload-
ed livers, the T2* decay is so rapid that most 
of the MRI signal will have irreversibly disap-
peared at the first in-phase TE (4.6 ms), mak-
ing accurate R2* estimation impossible.
Simultaneous estimation of T2* and fat 
fractions using multiecho gradient-echo tech-
niques such as IDEAL (iterative decomposi-
tion of water and fat with echo asymmetric 
and least-squares estimation) [9, 10] offers a 
logical approach to isolating signal from wa-
ter and fat. Fat has several spectral peaks, and 
a more accurate multifrequency model of fat 
can be included in the IDEAL technique, im-
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ron overload, resulting from disor-
ders of increased intestinal ab-
sorption or from repeated blood 
transfusions [1], is a problem of 
increasing clinical significance. The liver is 
the first organ to accumulate significant 
amounts of iron [2], and changes in liver iron 
concentration (LIC) account for 98% of the 
variation in total iron stores [3]. MRI relaxom-
etry has been increasingly used to quantify liv-
er iron, replacing liver biopsy as the standard 
of care for monitoring iron chelation therapy 
[4]. Both spin-echo (R2) and gradient-echo 
(R2*) estimates correlate highly with liver bi-
opsy [5, 6], but R2* approaches are more 
widely used because image acquisition is gen-
erally faster and easier to perform.
However, the utility of LIC estimation from 
R2* measurements has been hindered by dif-
ferences in acquisition and analysis tech-
niques. For example, there is no consensus re-
garding the effect of fat suppression on R2* 
LIC estimation. The coexistence of fat and 
iron in the liver are relatively common in pa-
tients with nontransfusional siderosis [7]. The 
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OBJECTIVE. The purpose of this study is to evaluate whether the application of spectral pre-
saturation inversion recovery (SPIR) fat suppression in standard multiecho gradient-echo sequenc-
es has a significant effect on hepatic R2* quantitation in patients with iron overload syndromes.
MATERIALS AND METHODS. Eighty patients were scanned with a multiecho gra-
dient-echo sequence without and with the application of SPIR. Six different postprocessing 
approaches were used to extract R2* values for maximum generality.
RESULTS. SPIR fat suppression lowered R2* values by 3.9–7.0% (p < 0.0001 in all pair-
wise comparisons), independently of the postprocessing algorithm. Coefficients of variation 
for R2* ranged from 4.5% to 10.0%. Regardless of the size of the ROI (area of homogeneous 
tissue or entire liver profile in the slice), pixelwise approaches combined with an exponen-
tial-plus-constant fitting model yielded the lowest coefficients of variation (4.5% and 5.1%), 
whereas truncated exponential fits of the averaged signals produced the highest coefficients 
of variation (7.8% and 10%). For R2* values exceeding 200 Hz, a Bland-Altman analysis 
showed a bias that grew linearly for all postprocessing methods.
CONCLUSION. SPIR fat suppression resulted in systematically lower hepatic R2* es-
timates. Because calibration curves were derived using images without fat suppression, these 
biases should be corrected when reporting liver iron concentrations estimated from fat-sup-
pressed multiecho T2*-weighted images.
Meloni et al.
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proving T2* estimation in the presence of fat 
for applications such as quantification of he-
patic iron overload [10]. Unfortunately, these 
techniques are currently not widely available, 
and implementation remains vendor specific.
Alternatively, conventional fat-suppression 
techniques, such as frequency-selective fat sat-
uration and inversion recovery fat nulling, can 
minimize fat signal contributions [11, 12]. Al-
though these approaches have no effect on R2 
LIC quantitation in iron-overloaded subjects 
[13], to our knowledge, there has been no sys-
tematic comparison examining the effect of fat 
suppression on R2* LIC estimation accuracy.
The aim of the current study was to evalu-
ate the effect of spectral presaturation inver-
sion recovery (SPIR) fat suppression on stan-
dard multiecho gradient-echo sequences and 
the derived hepatic R2* and LIC estimates 
in patients with iron overload syndromes. We 
examined six R2* postprocessing approach-
es to ensure generalizability.
Materials and Methods
Study Population
Beginning in January 2013, we acquired paired 
R2* assessments of liver iron with and without the 
use of SPIR fat suppression in all patients undergo-
ing clinical iron assessment. Our clinical practice 
has been to report non-fat-suppressed images unless 
there was evidence of severe steatosis. With increas-
ing reports of fat suppression use with LIC quanti-
fication in the literature, we decided to review our 
existing data to determine whether fat suppression 
altered image quality or quantification. We obtained 
a final cohort of 80 patients (28 with thalassemia 
major, 33 with sickle cell disease, and 19 with other 
transfusional and nontransfusional iron overload dis-
eases). The mean (± SD) age was 18.9 ± 10.4 years 
(age range, 2–53 years), and 25 patients were male.
The protocol for the conduct of this study was ap-
proved by The Children’s Hospital of Los Angeles’ 
Committee for the Protection of Human Subjects 
(CCI#12–00087). Waiver of informed consent was 
granted for the review of existing clinical data.
MRI Acquisition
All patients were scanned using a five-element 
torso coil on a single 1.5-T scanner (Achieva, Phil-
ips Healthcare). A multiecho gradient-echo se-
quence was used to collect the images for R2* anal-
ysis in a single end-expiratory breath-hold. A single 
midhepatic slice was acquired at 16 bipolar gradi-
ent-echoes evenly spaced from 1.0 to 13.4 ms. Im-
age parameters were as follows: TR, 50 ms; slice 
thickness, 10 mm; matrix, 128 × 128 pixels; receiv-
er bandwidth, 2273 Hz/pixel; and flip angle, 20°. 
The same sequence with identical parameters was 
obtained with SPIR fat suppression. This prepara-
tion sequence applies a frequency-specific inver-
sion pulse, ideally inverting only the fat magneti-
zation while leaving water resonances undisturbed. 
SPIR inversion uses a nonselective asymmetric 
sync pulse, with a flip angle of 120°, bandwidth of 
1 kHz, and an off-resonance frequency of −638 Hz. 
The gradient-echo excitation occurs as the fat mag-
netization passes through its null point at an inver-
sion time of 180 ms [14].
From here onward, we will refer to the R2* values 
obtained from the standard sequence (reference) as 
non-fat-suppressed R2* values and to those obtained 
from the sequence with the application of fat sup-
pression as fat-suppressed R2* values.
MRI Analysis
All R2* images were processed centrally by 
the same operator (with 6 years of experience) us-
ing custom-written software developed in Matlab 
(release 7.5, MathWorks).
Different analysis approaches were used to im-
prove the generalizability of the conclusions. Each 
analysis approach was defined by three different 
parameters, described here along with the possi-
ble alternatives. 
The first parameter is area of liver analyzed. Al-
ternatives are global analysis including the full ex-
tent of the liver within the slice, but excluding obvi-
ous major hilar vessels [5, 15], and ROI defined in 
an area of homogeneous liver tissue, avoiding blood 
vessels and other sources of artifacts [16–18].
The second parameter is type of fitting. Alterna-
tives are averaged-signal or region-based analysis, 
where pixels within the ROI are averaged together 
and fit is performed for this averaged decay curve 
[17, 18], and pixelwise analysis, where fitting is per-
formed for each pixel within the ROI and the median 
of the distribution of R2* values is calculated [5, 15]. 
The third parameter is curve-fitting models. 
One alternative to the curve-fitting model is a 
three-parameter model, which includes an expo-
nential with a variable offset [5, 16, 18], calculat-
ed as follows:
 S = S0e–TE 
·
 R2*
 + C (1),
where S is signal intensity, S0 is signal intensity at 
TE of 0, TE is TE, and C is constant offset that cor-
rects for contributions for blood, bile, motion ar-
tifact, and noise bias. The other alternative to the 
curve-fitting model is a two-parameter model, with 
a single exponential model (Equation 1 without the 
constant C) [17]. For moderate and high R2* val-
ues, fitting is performed after the manual exclusion 
of later TEs with high iron-mediated signal loss.
The two-parameter model cannot be combined 
with pixelwise fitting because there are no validat-
ed automatic truncation algorithms for liver signal 
decay, resulting in a total of six different algorithms 
(23 − 2), including those most often used clinical-
ly by different centers worldwide: PW_GA(3P) (i.e., 
pixelwise global analysis with three parameters) and 
Avg_ ROI(2P) (i.e., average ROI with two param-
eters). The algorithms are summarized in Table 1.
Statistical Analysis
All data were analyzed using SPSS (version 16.0, 
SPSS) and MedCalc (version 7.2.1.0 for Windows, 
MedCalc Software) statistical packages. Continu-
ous variables were described as mean ± SD.
For each approach, the following statistical com-
parison was made between fat-suppressed and 
non-fat-suppressed R2* estimates: the Wilcoxon 
signed-rank test was applied to detect statistically 
significant differences between two datasets. Sum-
mary data were displayed using scatterplots, and 
linear regression was performed. Linear regression 
models provided slope and intercept estimates and 
the coefficient of determination (R2), which mea-
TABLE 1: Description of Different Approaches Used to Calculate R2* Values 
and Nomenclature for the Respective R2* Algorithms
Algorithm Name Type of ROI Type of Fitting Curve-Fitting Model Reference
R2*_PW_GA(3P) Entire liver profile in 
the slice
Pixelwise approach Offset model  [5]
R2*_Avg_GA(3P) Entire liver profile in 
the slice
Averaged-signal 
approach
Offset model  [15]
R2*_Avg_GA(2P) Entire liver profile in 
the slice
Averaged-signal 
approach
Truncation model Not applicable
R2*_PW_ROI(3P) Area of homogeneous 
liver tissue
Pixelwise approach Offset model  [16]
R2*_Avg_ROI(3P) Area of homogeneous 
liver tissue
Averaged-signal 
approach
Offset model  [18]
R2*_Avg_ROI(2P) Area of homogeneous 
liver tissue
Averaged-signal 
approach
Truncation model  [17]
Note—Each approach is defined by three different aspects and two approaches differ for at least one of these 
aspects. PW = pixelwise, GA = global analysis, 3P = three parameter, Avg = average, 2P = two parameter.
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sures the goodness of the linear fit. The coefficient 
of variation was obtained as the ratio of the SD of 
the half mean square of the differences between the 
repeated values, to the general mean. A coefficient 
of variation less than 10% was considered good. The 
agreement between the variables was determined by 
Bland-Altman technique plotting the difference ver-
sus the average of the two measurements. Bias (sys-
tematic difference between methods) was the mean 
of the difference between the two R2* measure-
ments and agreement was the mean ± 1.96 SD. In 
each Bland-Altman plot, the regression line of dif-
ference was shown. All tests were performed with a 
significance level of α = 0.05.
Results
The R2* values obtained in this study com-
pletely spanned the clinically relevant range, 
varying from 34 to 1777 Hz, using our stan-
dard approach (pixelwise three-parameter fit). 
Table 2 and Figure 1 summarize the effect of 
fat suppression on R2* estimation. Fat sup-
pression lowered R2* values by 3.9–7.0% (p < 
0.0001 in all the pairwise comparisons), in-
dependently of the postprocessing algorithm.
Figure 2 shows the fat-suppressed R2* val-
ues as a function of non-fat-suppressed R2* 
values for each postprocessing algorithm 
along with its relative regression line. The re-
sults of each regression analysis are indicated 
in Table 2. All R2 values for the fit were near 
unity (lowest value = 0.975; highest value = 
0.994). However, all the slopes were signifi-
cantly less than 1 (range, 0.897–0.975).
Coefficients of variation ranged from 
4.5% to 10.0% (Table 2). Pixelwise ap-
proaches yielded the lowest coefficient of 
variation (4.5% and 5.1%); truncated expo-
nential fits produced higher coefficients of 
variation (7.8% and 10%).
Figure 3 shows the Bland-Altman plots. 
No bias was apparent until R2* exceeded 
200 Hz, but it grew linearly thereafter for all 
six postprocessing methods.
Discussion
To our knowledge, this is the first study to 
compare the effect of SPIR fat suppression 
on R2* quantitation in transfusional sider-
osis. We have shown that SPIR fat suppres-
sion systematically lowered R2* estimates 
by 3.9–7.0% and introduced comparable ran-
dom uncertainty between the two measure-
ments. Because calibration curves have been 
derived using non-fat-saturated images [5, 17, 
19], these biases should be corrected when re-
porting LIC values from fat-saturated images.
There are two explanations for the differ-
ence in fat-suppressed and non-fat-suppressed 
R2* estimates. First, fat and water cannot be 
separated by radiofrequency excitations in 
iron-overloaded subjects. Iron causes over-
lap of the water and fat line width’s for LIC 
concentrations greater than approximately 5 
mg/g (R2* > 220 Hz) at 1.5 T. As a result, 
the SPIR preparation suppresses significant 
amounts of the water signal from heavily iron-
loaded tissues, lowers the signal-to-noise ratio 
in an iron-dependent manner, and biases R2* 
estimates toward lower values. Figure 3 shows 
that bias and variability increase dramatical-
ly once liver R2* exceeds 200 Hz. Second, 
the fat-water signal modulation with TE in-
fluences whether weak echoes are retained or 
truncated. Because SPIR preparation reduces 
TABLE 2: Comparison Between Hepatic R2* Values and Hepatic R2* Values With Application of Fat Suppression for 
Each Approach Adopted for R2* Calculation
Algorithm
Paired-Sample Wilcoxon Signed-Rank Test Regression Analysis
Difference 
(%)
Coefficient of 
Variation (%)
Fat-Suppressed vs 
Non-Fat-Suppressed (Hz)
Difference 
(Hz) p
Slope, 
Coefficient (SE) p for Slope
Intercept (Hz), 
Coefficient (SE) R 2
R2*_PW_GA(3P) 677.5 ± 472.3 
vs 706.0 ± 486.7
−28.5 ± 41.5 < 0.0001 0.967 (0.009) 0.00029 −5.388 (7.620) 0.993 −4.2 ± 5.1 5.1
R2*_Avg_GA(3P) 605.9 ± 388.5 
vs 638.6 ± 416.1
−32.7 ± 52.2 < 0.0001 0.928 (0.012) < 0.0001 13.283 (8.861) 0.988 −3.9 ± 6.7 7.0
R2*_Avg_GA(2P) 468.3 ± 276.2 
vs 506.6.6 ± 298.9
−38.4 ± 37.7 < 0.0001 0.919 (0.011) < 0.0001 2.684 (6.437) 0.989 −6.8 ± 7.7 7.8
R2*_PW_ROI(3P) 674.3 ± 466.5 
vs 698.6 ± 477.2
−24.3 ± 36.6 < 0.0001 0.975 (0.008) 0.0025 −6.692 (6.936) 0.994 −4.2 ± 6.6 4.5
R2*_Avg_ROI(3P) 665.5 ± 458.6 
vs 695.5 ± 475.6
−30.2 ± 51.6 < 0.0001 0.959 (0.011) 0.0004 −1.593 (9.568) 0.989 −4.7 ± 7.4 6.2
R2*_Avg_ROI(2P) 557.2 ± 361.9 
vs 599.7 ± 398.4
−42.5 ± 70.3 < 0.0001 0.897 (0.016) < 0.0001 19.229 (11.669) 0.975 −7.0 ± 9.4 10.0
Note—Except where noted otherwise, data are mean ± SD. SE = standard error, PW = pixelwise, GA = global analysis, 3P = three parameter, Avg = average, 2P = two parameter.
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Fig. 1—Effect of fat suppression on R2* estimation. 
Regression slope (left) is shown as function of 
fitting model. Error bars denote 95% CIs. Bias 
and coefficient of variation are shown for images 
collected with and without saturation (right). Bias is 
displayed as absolute value to facilitate plotting (fat 
saturation consistently lowered R2* estimates). 2P = 
two parameter, 3P = three parameter, Avg = average, 
PW = pixelwise.
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both the fat and water signals, this truncation 
process becomes less reliable. This is quite 
evident in Figure 1, where the combined de-
viation (bias plus coefficients of variation) is 
much higher (≈ 15%) for truncation (two-pa-
rameter model) methods. The three-parame-
ter model generally is more robust to fat sup-
pression because it fits the entire echo train, 
where in-phase and out-of-phase oscillations 
have contributed three full cycles, contribut-
ing approximately equal positive and negative 
fitting errors to the dominant exponential.
This study was limited by the use of a sin-
gle type of fat suppression approach (SPIR), 
which is implemented by the vendor. SPIR 
does not account for the multispectral nature 
of fat resonances. Although the fundamen-
tal interactions between iron, fat, and fitting 
models are a physical reality, the effect size 
observed in this study may vary across sup-
pression methods and platforms. For exam-
ple, fat-suppression techniques exploiting T1 
differences between fat and liver will suffer 
from incomplete separation as liver T1 short-
ens with iron overload, but the magnitude of 
the bias may be different than observed in our 
study. Similar caveats must be made for oth-
er fitting models, such as those that attempt 
to correct for noise bias through statistical 
methods. This study would also have been 
strengthened by formal signal-to-noise ratio 
assessment, but the use of a proprietary sur-
face correction and background noise sup-
pression (CLEAR [Constant LEvel AppeaR-
ance], Philips Healthcare) create spatially 
varying noise characteristics.
Fat suppression has not been routine in R2* 
LIC estimation, but some groups have recently 
been advocating its use, particularly with the 
ROI_Avg(2P) (average ROI with two param-
eters) model [12]. Our data suggest that SPIR 
fat suppression is inappropriate for patients 
with transfusional siderosis because it reduces 
signal to noise, biases the R2* estimate, and 
adds unnecessary measurement variability 
into the R2* estimate. Errors introduced by 
fat saturation (worst case 95% CIs, −25.8% to 
11.8%) are not large enough to completely al-
ter patient management, but sufficiently large 
to warrant controlling. However, SPIR sup-
pression could be beneficial in patients with 
high hepatic lipid content and low liver iron 
burden, such as patients with metabolic syn-
drome [20]; however, reasonable R2* estima-
tion can be performed in these subjects by re-
stricting TEs to in-phase echoes only.
The optimal way to correct for fat-water 
signal modulations is to perform simultane-
ous modeling of the T2* decay and fat in-
teractions, using models that account for the 
spectral off-resonance characteristics of mo-
bile lipids [9, 10]. We think that these meth-
ods will gradually replace simple multiecho 
gradient-echo R2* techniques over time, but 
limited availability and platform specific-
ity prohibit their widespread use presently. 
Fortunately, patients undergoing long-term 
transfusion rarely have significant hepat-
ic steatosis because chronic anemia states 
are generally hypermetabolic [21], explain-
ing why R2* LIC approaches are so robust 
in these patients. If fat suppression is used at 
individual centers, paired analysis detailing 
the effect of fat saturation on the calibration 
curve should be performed.
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